JATT Acquisition (JATT) Competitors $1.26 -0.02 (-1.56%) As of 06/11/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock JATT vs. PYRGF, INCR, SRZN, IMRX, MNOV, SKYE, VTGN, BYSI, ZIVO, and ANROShould you be buying JATT Acquisition stock or one of its competitors? The main competitors of JATT Acquisition include PyroGenesis Canada (PYRGF), InterCure (INCR), Surrozen (SRZN), Immuneering (IMRX), MediciNova (MNOV), Skye Bioscience (SKYE), Vistagen Therapeutics (VTGN), BeyondSpring (BYSI), ZIVO Bioscience (ZIVO), and Alto Neuroscience (ANRO). These companies are all part of the "pharmaceutical products" industry. JATT Acquisition vs. Its Competitors PyroGenesis Canada InterCure Surrozen Immuneering MediciNova Skye Bioscience Vistagen Therapeutics BeyondSpring ZIVO Bioscience Alto Neuroscience PyroGenesis Canada (NASDAQ:PYRGF) and JATT Acquisition (NYSE:JATT) are both small-cap industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, community ranking, profitability, analyst recommendations, earnings and dividends. Do insiders and institutionals believe in PYRGF or JATT? 0.0% of PyroGenesis Canada shares are held by institutional investors. Comparatively, 48.0% of JATT Acquisition shares are held by institutional investors. 47.7% of PyroGenesis Canada shares are held by company insiders. Comparatively, 20.0% of JATT Acquisition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is PYRGF or JATT more profitable? JATT Acquisition has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat JATT Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets PyroGenesis Canada-115.14% N/A -60.81% JATT Acquisition N/A -49.58%2.84% Does the media favor PYRGF or JATT? In the previous week, PyroGenesis Canada had 3 more articles in the media than JATT Acquisition. MarketBeat recorded 3 mentions for PyroGenesis Canada and 0 mentions for JATT Acquisition. JATT Acquisition's average media sentiment score of 0.00 beat PyroGenesis Canada's score of -0.50 indicating that JATT Acquisition is being referred to more favorably in the news media. Company Overall Sentiment PyroGenesis Canada Negative JATT Acquisition Neutral Does the MarketBeat Community prefer PYRGF or JATT? PyroGenesis Canada and JATT Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPyroGenesis CanadaN/AN/AJATT AcquisitionN/AN/A Which has stronger earnings and valuation, PYRGF or JATT? JATT Acquisition has lower revenue, but higher earnings than PyroGenesis Canada. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPyroGenesis Canada$9.14M6.88-$21.12M-$0.02-16.85JATT AcquisitionN/AN/A$6.85MN/AN/A SummaryJATT Acquisition beats PyroGenesis Canada on 5 of the 9 factors compared between the two stocks. Get JATT Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for JATT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JATT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JATT vs. The Competition Export to ExcelMetricJATT AcquisitionBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$21.74M$3.11B$5.60B$19.86BDividend YieldN/A1.57%5.28%3.83%P/E RatioN/A33.1427.2535.60Price / SalesN/A468.68413.3545.07Price / Cash27.08168.6838.2517.51Price / Book-2.383.437.124.84Net Income$6.85M-$72.35M$3.24B$1.02B7 Day Performance6.78%7.30%2.71%1.88%1 Month Performance4.13%17.78%8.93%2.98%1 Year Performance-67.10%-16.89%31.30%9.82% JATT Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JATTJATT AcquisitionN/A$1.26-1.6%N/A-66.0%$21.74MN/A0.003High Trading VolumePYRGFPyroGenesis Canada0.1614 of 5 stars$0.39+0.1%N/A-20.8%$72.32M$9.14M-6.4690Short Interest ↑Gap DownINCRInterCure0.2683 of 5 stars$1.57+1.9%N/A-36.3%$71.55M$238.85M0.00350Short Interest ↑Gap DownSRZNSurrozen3.797 of 5 stars$8.31-1.1%$38.50+363.3%-20.9%$71.16M$11.64M-0.3380Positive NewsIMRXImmuneering2.9746 of 5 stars$1.96flat$15.33+682.3%+25.4%$70.53M$320K-0.9960News CoverageShort Interest ↑MNOVMediciNova2.1401 of 5 stars$1.43+1.4%$9.00+529.4%+2.3%$70.14M$1M-6.2210SKYESkye Bioscience1.8156 of 5 stars$2.24-2.2%$16.60+641.1%-78.8%$69.38MN/A-2.7311Analyst RevisionGap UpVTGNVistagen Therapeutics1.4137 of 5 stars$2.39flatN/A-37.4%$68.98M$698K-1.6140News CoveragePositive NewsGap DownBYSIBeyondSpringN/A$1.69-0.6%N/A+23.3%$68.13M$1.88M0.0080Positive NewsZIVOZIVO Bioscience0.4927 of 5 stars$17.51-6.5%N/A+75.5%$66.77M$15.85K-3.5910Positive NewsGap UpANROAlto Neuroscience1.6903 of 5 stars$2.44-7.2%$15.40+531.1%-79.4%$66.06MN/A-1.04N/A Related Companies and Tools Related Companies PYRGF Alternatives INCR Alternatives SRZN Alternatives IMRX Alternatives MNOV Alternatives SKYE Alternatives VTGN Alternatives BYSI Alternatives ZIVO Alternatives ANRO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:JATT) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JATT Acquisition Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share JATT Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy JATT Stock Free JATT Stock Alerts